Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Avalo Therapeutics ROA 2014-2025 | AVTX

Current and historical return on assets (ROA) values for Avalo Therapeutics (AVTX) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Avalo Therapeutics ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2025-09-30 $0.01B $0.13B 8.12%
2025-06-30 $0.05B $0.13B 36.50%
2025-03-31 $0.07B $0.14B 58.06%
2024-12-31 $-0.04B $0.15B -29.94%
2024-09-30 $-0.12B $0.10B -136.75%
2024-06-30 $-0.13B $0.11B -184.40%
2024-03-31 $-0.14B $0.12B -286.87%
2023-12-31 $-0.03B $0.02B -112.73%
2023-09-30 $-0.03B $0.03B -108.20%
2023-06-30 $-0.03B $0.02B -76.92%
2023-03-31 $-0.03B $0.04B -86.96%
2022-12-31 $-0.04B $0.03B -102.44%
2022-09-30 $-0.05B $0.04B -96.68%
2022-06-30 $-0.07B $0.03B -105.58%
2022-03-31 $-0.08B $0.06B -99.67%
2021-12-31 $-0.08B $0.08B -111.26%
2021-09-30 $-0.08B $0.10B -121.80%
2021-06-30 $-0.08B $0.06B -133.91%
2021-03-31 $-0.07B $0.06B -124.26%
2020-12-31 $-0.06B $0.04B -116.67%
2020-09-30 $-0.05B $0.06B -86.54%
2020-06-30 $-0.04B $0.07B -69.90%
2020-03-31 $-0.03B $0.04B -58.88%
2019-12-31 $-0.02B $0.04B -26.32%
2019-09-30 $-0.02B $0.06B -35.11%
2019-06-30 $-0.04B $0.06B -64.47%
2019-03-31 $-0.04B $0.08B -64.00%
2018-12-31 $-0.04B $0.07B -61.89%
2018-09-30 $-0.04B $0.07B -70.59%
2018-06-30 $0.00B $0.06B 4.04%
2018-03-31 $0.01B $0.07B 16.90%
2017-12-31 $0.01B $0.04B 39.51%
2017-09-30 $0.01B $0.03B 118.18%
2017-06-30 $-0.01B $0.01B -184.62%
2017-03-31 $-0.01B $0.00B -169.70%
2016-12-31 $-0.02B $0.01B -147.83%
2016-09-30 $-0.02B $0.01B -122.58%
2016-06-30 $-0.01B $0.01B -98.25%
2016-03-31 $-0.01B $0.02B -118.18%
2015-12-31 $-0.01B $0.02B -162.96%
2015-06-30 $-0.01B $0.00B 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.306B $0.000B
Avalo Therapeutics Inc. is a clinical-stage precision medicine company which discovers, develops and commercializes targeted therapeutics for patients with significant unmet clinical need in immunology, immuno-oncology and rare genetic diseases. Avalo Therapeutics Inc., formerly known as Cerecor, is based in WAYNE, Pa.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $89.154B 33.86
Zoetis (ZTS) United States $52.354B 18.74
Takeda Pharmaceutical (TAK) Japan $44.993B 9.18
BeOne Medicines - (ONC) Switzerland $44.644B 218.97
Daiichi Sankyo, - (DSNKY) Japan $41.960B 20.90
Sandoz Group AG (SDZNY) Switzerland $30.210B 0.00
United Therapeutics (UTHR) United States $20.319B 17.88
Merck (MKKGY) Germany $17.344B 10.69
Shionogi (SGIOY) Japan $14.581B 13.39
Neurocrine Biosciences (NBIX) United States $14.314B 34.34
Summit Therapeutics (SMMT) United States $13.071B 0.00
IPSEN (IPSEY) France $12.602B 0.00
Madrigal Pharmaceuticals (MDGL) United States $12.569B 0.00
Ionis Pharmaceuticals (IONS) United States $11.866B 0.00
Orion OYJ (ORINY) Finland $9.803B 28.01
Eisai (ESAIY) $8.668B 0.00
Corcept Therapeutics (CORT) United States $7.902B 85.36
Stevanato Group S.p.A (STVN) Italy $6.514B 36.46
Grifols, S.A (GRFS) Spain $5.844B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.204B 15.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.586B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $4.372B 0.00
Crinetics Pharmaceuticals (CRNX) United States $4.130B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $3.672B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.640B 17.28
Hypermarcas (HYPMY) Brazil $3.072B 21.09
Procaps Group, S.A (PROCF) Luxembourg $2.926B 0.00
Dyne Therapeutics (DYN) United States $2.891B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.773B 8.85
Soleno Therapeutics (SLNO) United States $2.538B 0.00
Ocular Therapeutix (OCUL) United States $2.533B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $2.248B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.042B 24.20
Guardian Pharmacy Services (GRDN) United States $1.794B 34.55
Amylyx Pharmaceuticals (AMLX) United States $1.535B 0.00
Harrow (HROW) United States $1.492B 91.57
BioCryst Pharmaceuticals (BCRX) United States $1.480B 87.88
Ardelyx (ARDX) United States $1.436B 0.00
Collegium Pharmaceutical (COLL) United States $1.433B 7.10
Oruka Therapeutics (ORKA) United States $1.367B 0.00
Enliven Therapeutics (ELVN) United States $1.291B 0.00
Nektar Therapeutics (NKTR) United States $1.212B 0.00
Xeris Biopharma Holdings (XERS) United States $1.205B 0.00
Relay Therapeutics (RLAY) United States $1.147B 0.00
Xencor (XNCR) United States $1.115B 0.00
Evotec AG (EVO) Germany $1.052B 0.00
Cronos Group (CRON) Canada $0.927B 0.00
Theravance Biopharma (TBPH) United States $0.914B 38.38
Savara (SVRA) United States $0.855B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.772B 6.89
Organogenesis (ORGO) United States $0.760B 0.00
KalVista Pharmaceuticals (KALV) United States $0.751B 0.00
ARS Pharmaceuticals (SPRY) United States $0.724B 0.00
Aquestive Therapeutics (AQST) United States $0.710B 0.00
Lexeo Therapeutics (LXEO) United States $0.692B 0.00
Esperion Therapeutics (ESPR) United States $0.674B 0.00
ProKidney (PROK) United States $0.662B 0.00
4D Molecular Therapeutics (FDMT) United States $0.626B 0.00
Elite Pharmaceuticals (ELTP) United States $0.624B 0.00
Bioventus (BVS) United States $0.584B 11.97
Zevra Therapeutics (ZVRA) United States $0.517B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.508B 12.04
Akebia Therapeutics (AKBA) United States $0.467B 0.00
Altimmune (ALT) United States $0.437B 0.00
Siga Technologies (SIGA) United States $0.423B 5.78
Galectin Therapeutics (GALT) United States $0.387B 0.00
Lyell Immunopharma (LYEL) United States $0.370B 0.00
Nature's Sunshine Products (NATR) United States $0.359B 21.39
USANA Health Sciences (USNA) United States $0.346B 9.65
Silence Therapeutics (SLN) United Kingdom $0.316B 0.00
Aldeyra Therapeutics (ALDX) United States $0.298B 0.00
Larimar Therapeutics (LRMR) United States $0.292B 0.00
Pyxis Oncology (PYXS) United States $0.290B 0.00
Aclaris Therapeutics (ACRS) United States $0.265B 0.00
Achieve Life Sciences (ACHV) Canada $0.234B 0.00
OmniAb (OABI) United States $0.219B 0.00
Protara Therapeutics (TARA) United States $0.215B 0.00
AleAnna (ANNA) United States $0.211B 0.00
MediWound (MDWD) Israel $0.204B 0.00
Journey Medical (DERM) United States $0.202B 0.00
Heron Therapeutics (HRTX) United States $0.200B 0.00
Profound Medical (PROF) Canada $0.195B 0.00
Innate Pharma SA (IPHYF) France $0.168B 0.00
China SXT Pharmaceuticals (SXTC) China $0.157B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.147B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.138B 0.00
Cassava Sciences (SAVA) United States $0.134B 0.00
Relmada Therapeutics (RLMD) United States $0.132B 0.00
Unicycive Therapeutics (UNCY) United States $0.124B 0.00
Avita Medical (RCEL) United States $0.118B 0.00
Incannex Healthcare (IXHL) Australia $0.117B 0.00
Inhibikase Therapeutics (IKT) United States $0.114B 0.00
Surrozen (SRZN) United States $0.110B 0.00
Vivani Medical (VANI) United States $0.107B 0.00
Context Therapeutics (CNTX) United States $0.106B 0.00
Prelude Therapeutics (PRLD) United States $0.104B 0.00
Gain Therapeutics (GANX) United States $0.102B 0.00
Karyopharm Therapeutics (KPTI) United States $0.099B 0.00
Cardiol Therapeutics (CRDL) Canada $0.098B 0.00
VAXART, INC (VXRT) United States $0.094B 0.00
Champions Oncology (CSBR) United States $0.093B 33.75
PMV Pharmaceuticals (PMVP) United States $0.076B 0.00
Acrivon Therapeutics (ACRV) United States $0.075B 0.00
Dominari Holdings (DOMH) United States $0.074B 0.00
Assertio Holdings (ASRT) United States $0.072B 0.00
Fractyl Health (GUTS) United States $0.072B 0.00
Lite Strategy (LITS) United States $0.070B 0.00
Plus Therapeutics (PSTV) United States $0.065B 0.00
Nutriband (NTRB) United States $0.065B 0.00
Metagenomi (MGX) United States $0.064B 0.00
Rafael Holdings (RFL) United States $0.063B 0.00
Talphera (TLPH) United States $0.062B 0.00
BioNxt Solutions (BNXTF) Canada $0.061B 0.00
Korro Bio (KRRO) United States $0.058B 0.00
PolyPid (PYPD) Israel $0.058B 0.00
Wellgistics Health (WGRX) United States $0.052B 0.00
Telomir Pharmaceuticals (TELO) United States $0.048B 0.00
Jupiter Neurosciences (JUNS) United States $0.044B 0.00
ElectroCore (ECOR) United States $0.042B 0.00
Century Therapeutics (IPSC) United States $0.042B 0.00
NRx Pharmaceuticals (NRXP) United States $0.042B 0.00
Tempest Therapeutics (TPST) United States $0.042B 0.00
Mural Oncology (MURA) Ireland $0.036B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.035B 0.00
FibroGen (FGEN) United States $0.035B 0.00
Klotho Neurosciences (KLTO) United States $0.034B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.033B 0.00
Liminatus Pharma (LIMN) United States $0.029B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.028B 23.75
Vyome Holdings (HIND) United States $0.028B 0.00
Cosmos Health (COSM) United States $0.024B 0.00
SCYNEXIS (SCYX) United States $0.024B 0.00
Scienture Holdings (SCNX) United States $0.024B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
Inotiv (NOTV) United States $0.024B 0.00
Iterum Therapeutics (ITRM) Ireland $0.019B 0.00
Natural Alternatives (NAII) United States $0.018B 0.00
Mannatech (MTEX) United States $0.018B 0.00
Vivos Therapeutics (VVOS) United States $0.018B 0.00
TherapeuticsMD (TXMD) United States $0.018B 0.00
Lipocine (LPCN) United States $0.017B 0.00
Traws Pharma (TRAW) United States $0.017B 0.02
MARKER THERAPEUTICS, INC (MRKR) United States $0.016B 0.00
Citius Pharmaceuticals (CTXR) United States $0.016B 0.00
Heatwurx (PCSA) United States $0.015B 0.00
BioLineRx (BLRX) Israel $0.015B 0.00
CASI Pharmaceuticals (CASI) China $0.015B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.014B 0.00
Mangoceuticals (MGRX) United States $0.013B 0.00
VYNE Therapeutics (VYNE) United States $0.012B 0.00
Ernexa Therapeutics (ERNA) United States $0.012B 0.00
ProPhase Labs (PRPH) United States $0.011B 0.00
BioVie (BIVI) United States $0.011B 0.00
Ainos (AIMD) United States $0.011B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
Phio Pharmaceuticals (PHIO) United States $0.008B 0.00
Alaunos Therapeutics (TCRT) United States $0.007B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
Biomerica (BMRA) United States $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Qualigen Therapeutics (QLGN) United States $0.005B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.005B 0.00
Nuvilex (PMCB) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
CDT Equity (CDT) United States $0.003B 0.00
Indaptus Therapeutics (INDP) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
Indivior (INDV) United States $0.000B 16.01
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00